openPR Logo
Press release

U.S. Biochip Products and Services Market to Increasing Applications of Microarrays in 2018

01-03-2017 06:17 AM CET | Health & Medicine

Press release from: TMR - Research Reports

U.S. Biochip Products and Services Market to Increasing

The high degree of rivalry between players characterizes the landscape of the U.S. biochip products and services market, finds a new study by Transparency Market Research (TMR). According to this study, the market demonstrates an oligopolistic structure and is led by Illumina Inc., Affymetrix Inc., and Life Technologies Corp. In the recent times, the count of participants in this market has significantly increased, thanks to the rise in government funding to encourage genetic research and cancer treatment. As a result, the competition within the market has intensified considerably.

Analysts expect the competition to remain intense in the near future as a number of biochip products and services providers, based outside of the U.S. such as Technology Center Dortmund GmbH, Scienion AG, and Arrayjet Ltd., are trying to expand their reach in this market through product launches and strategic alliances.

As per TMR, the U.S. market for biochip products and services presented an opportunity worth US$2.4 bn in 2011. The market is estimated to increase at a CAGR of 10.10% between 2012 and 2018 and reach US$4.7 bn by the end of the forecast period. Microarrays have attracted strong demand in the recent past and are likely to gain substantial momentum in the near future too. The segment is expected to hold a share of 57.4% in the overall demand for biochip products and services by 2018.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1160

Drug Delivery to Continue to Exhibit Strong Demand for Biochip Products and Services

The report assesses this market on the basis of the key applications of biochip products and services, that is, in-vitro diagnostic testing, drug delivery, science research, forensic medicine, defense, and disease management. The drug delivery segment has emerged as the prime application area for these products and services on account of the increasing utilization of biochip technology in single nucleotide polymorphism (SNP) identification and genotyping, protein analysis, gene expression analysis, and characterization in drug delivery. The opportunity for biochip products and services in this segment is expected to reach US$2.5 bn by the end of 2018.

Rising Application of Genomics and Proteomics in Cancer Research and DNA Microarrays in Drug Delivery to Boost Market

“The increase in advanced research due to the growing prevalence of cancer and other life-threatening diseases has been fueling the demand for biochip products and services remarkably,” says the author of this report. For instance, the application of genomics and proteomics has increased significantly in cancer research activities and the demand for DNA microarrays has been gaining impetus in drug discovery over the recent past. The trend is expected to continue over the next few years, driving the U.S. market for biochip products and services remarkably.

The application of these products and services is also projected to rise in the manufacturing of personalized medicines and life-science research in the years to come, resulting in the significant growth of this market.

Costly Procedure of Biochip Production to Affect U.S. Biochip Products and Services Market

While the market exhibits strong growth prospects, the complicated and costly procedure of biochip production may obstruct its growth trajectory in the coming years. The availability of alternative technologies such as polymerase chain reactions, and mass spectrometry may also affect the market to some extent in the near future, states the report.

The study presented here is based on a report by Transparency Market Research (TMR) titled “Biochip Products and Services Market - (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018.”

Browse Full Research Report on Biochip Products and Services Market:
http://www.transparencymarketresearch.com/biochip-products-services.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release U.S. Biochip Products and Services Market to Increasing Applications of Microarrays in 2018 here

News-ID: 404028 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Biochip

Biochip Market Size, Share, Growth & Industry Report Analysis 2032
Biochip Market Overview The biochip market refers to the use of microchips that integrate biological molecules such as DNA, proteins, and enzymes for diagnostics, drug development, and genetic testing. These compact devices offer high-throughput screening and multiplexing capabilities, enabling advancements in personalized medicine and disease detection. With the rise in chronic diseases, such as cancer, diabetes, and cardiovascular diseases, biochips are becoming essential in early diagnosis, monitoring, and precision treatment. As
Biochip Market Size, Share, Report and Forecast 2024-2032
The global biochip market size was valued at USD 6.7 billion in 2023, driven by the rising prevalence of chronic diseases, and increased preference for personalized medicine across the globe. The market is expected to grow at a CAGR of 14.36% during the forecast period of 2024-2032, with the values likely to rise from USD 14.2 billion in 2024 to USD 41.4 billion by 2032. Biochip: Introduction Biochips are miniature laboratories that
Global Automatic Biochip Reader Market Research Report 2023-2029
Automatic Biochip Reader report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Automatic Biochip Reader market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Tumor Detection and Drug Screening are the major drivers for the industry. Global Leading Market Research Publisher QYResearch announces
Liquid Biochip Analyzer Market Analysis,Demand,Trends and Forecast 2029
Global Info Research announces the release of the report "Global Liquid Biochip Analyzer Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029" . The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets.
Global Biochip Reader Market - Opportunities & Forecasts, 2020-2029
Dhirtek Business Research and Consulting recently released its most comprehensive research report to date on the global biochip reader market. Through extensive research, analysts have provided an extensive look into the market's drivers and restraints, and identified the key milestones and trends that will shape its future. Primary and secondary research methods were used to create this in-depth report. Through the analysis of the research, Dhirtek was able to identify the
Biochip Market 2022 | Detailed Report
The Biochip research report provides a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The data thus presented is reliable, comprehensive and the result of extensive research both primary and secondary. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. Moreover, the data underlines the primary and secondary drivers, market